[roadnottaken]

It is still going strong in bioinformatics/genomics. I think it's slower and clunkier than the alternatives, but for stats and graphics it's pretty easy for scientists to learn...

[michaels0620]

It's also slowly getting a foot hold in Pharma. I think the large Pharma companies would love to get out from under the expensive SAS licenses.